Anagen effluvium
Alerts and Notices
Important News & Links
Synopsis
![Anagen effluvium](/visualdx/sympticonswm/3740.png?r=1fdb69a28)
Anagen effluvium can occur in up to 65% of patients undergoing chemotherapy. Drugs implicated include antimicrotubule agents (eg, paclitaxel), topoisomerase inhibitors (eg, doxorubicin), alkylating agents (eg, cyclophosphamide), and antimetabolites (eg, 5-fluorouracil). Other medications such as bismuth, levodopa, colchicine, and cyclosporine, and exposure to toxic chemicals such as thallium, mercury, boron, copper, or cadmium, have also been implicated. Although drug-induced alopecia is usually reversible upon discontinuation of the culprit medication, permanent alopecia from chemotherapy (taxane and adjuvant hormonal therapy) has been reported.
Other causes of anagen effluvium include protein malnutrition, pemphigus vulgaris, systemic lupus erythematosus, alopecia areata, and secondary syphilis. Finally, radiation therapy is a known trigger and may result in irreversible alopecia (radiation-induced alopecia).
Anagen effluvium is self-limiting, and the duration of disease is dependent on the duration of toxic insult.
High dosages of drug therapy and polypharmacy might be associated with a more severe phenotype.
Codes
L65.1 – Anagen effluvium
SNOMEDCT:
86160006 – Anagen effluvium
Look For
Subscription Required
Diagnostic Pearls
Subscription Required
Differential Diagnosis & Pitfalls
Subscription Required
Best Tests
Subscription Required
Management Pearls
Subscription Required
Therapy
Subscription Required
Drug Reaction Data
Subscription Required
References
Subscription Required
Last Updated:07/16/2018